Evogene Ltd. EVGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -35.02% | -79.65% | -11.74% | -44.08% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -35.02% | -79.65% | -11.74% | -44.08% | |
| Cost of Revenue | 51.47% | 230.06% | -59.52% | 389.35% | |
| Gross Profit | -64.57% | -331.49% | 47.96% | -78.71% | |
| SG&A Expenses | -14.21% | -26.81% | -33.52% | -40.55% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -170.00% | -- | -- | |
| Total Operating Expenses | -22.06% | 5.12% | -39.89% | -28.31% | |
| Operating Income | 19.41% | -42.70% | 43.57% | 9.78% | |
| Income Before Tax | 57.96% | -639.19% | 49.72% | 50.51% | |
| Income Tax Expenses | -500.00% | -100.00% | 0.00% | -- | |
| Earnings from Continuing Operations | 58.11% | -643.03% | 49.71% | 50.51% | |
| Earnings from Discontinued Operations | 69.72% | 98.38% | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -100.46% | -89.58% | -61.31% | 2,333.33% | |
| Net Income | 60.38% | -1,343.33% | 17.66% | 33.03% | |
| EBIT | 19.41% | -42.70% | 43.57% | 9.78% | |
| EBITDA | 16.65% | -5.12% | 44.94% | -0.41% | |
| EPS Basic | 76.53% | -1,069.75% | 41.99% | 49.93% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | 76.53% | -1,069.75% | 41.99% | 49.93% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | 68.84% | 28.29% | 41.93% | 33.74% | |
| Average Diluted Shares Outstanding | 68.84% | 28.29% | 41.93% | 33.74% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |